Previous close | 27.52 |
Open | 27.43 |
Bid | 0.00 x 1200 |
Ask | 30.20 x 4000 |
Day's range | 27.41 - 27.83 |
52-week range | 23.78 - 32.59 |
Volume | |
Avg. volume | 4,285,757 |
Market cap | 11.189B |
Beta (5Y monthly) | 0.47 |
PE ratio (TTM) | 17.89 |
EPS (TTM) | 1.54 |
Earnings date | 21 Feb 2023 - 27 Feb 2023 |
Forward dividend & yield | 1.00 (3.63%) |
Ex-dividend date | 06 Feb 2023 |
1y target est | 30.45 |
Lazard (NYSE: LAZ), AbbVie (NYSE: ABBV), and NiSource (NYSE: NI) don't have much in common other than they are all U.S. companies that are a little bit underappreciated. Investment firm Lazard and utility company NiSource are perhaps not as widely known to some investors, so it's not surprising that they might trade below 19 times forward earnings.
China’s re-opening may take a bite out of the country’s all-important auto sector. The South China Morning Post (SCMP) reports that a flare-up in Covid-19 cases will hit China’s EV industry, resulting in a loss of 600,000 in EV sales in the first quarter of next year. Citing data from the partially owned China International Capital Corporation (CICC), the report finds that the flare up in cases will create disrupted production, and reduced demand.
Conagra Brands (CAG), Radian Group (RDN), Lazard (LAZ), NiSource (NI) and Citizens Financial Group are part of the Zacks top Analyst Blog.